Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization

StatusTerminated
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial terminated Sponsor's reason: poor accrual and insufficient drug supply Show 5 more changesShow less
    • Primary completion date changed from estimate of Dec 31, 2025 to Oct 2, 2026
    • Final enrollment: 23 participants (planned 60)
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
Effects of Antrodia cinnamomea on the hepatoma patients after Transcatheter hepatic artery chemoembolization
Trial Details
NCT Number NCT07178093
Lead Sponsor Taichung Tzu Chi Hospital
Conditions
(from sponsor)		 Hepatocellular Carcinoma, Transarterial Chemoembolization
Related terms Carcinoma, Hepatocellular
Enrollment 23 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov